ライフサイエンス研究メディア

バイオマーケットjpはバイオ・ライフサイエンス研究に役立つ情報を発信するWebメディアです

An exploratory analysis of extracellular vesicle-associated and soluble cytokines in cancer-related fatigue in men with prostate cancer


Posted: 2021-09-30 19:00:00
Background: Cancer Related Fatigue (CRF) is one of the most prevalent and distressing symptoms associated with cancer treatments. The exact etiology of CRF and its mechanisms are poorly understood. Cytokine dysregulation was hypothesized to be one of these mechanisms. Here, we explored the associations of soluble and extracellular vesicle (EV)-associated markers that include cytokines, heat shock proteins (hsp27, hsp70, hsp90), and neurotrophic factors (BDNF) with CRF. Methods: Plasma was collected from men (n ​= ​40) with non-metastatic prostate cancer receiving external beam radiation therapy (EBRT) at the start of the treatment, and three months after EBRT. CRF was assessed using the Functional Assessment of Cancer Therapy - Fatigue (FACT-F) from all participants. EVs were characterized via Nanoparticle Tracking Analysis, electron microscopy, and Western blot. Concentrations of EV-associated and soluble markers were measured with a multiplexed immunoassay system. Bivariate correlation analyses and independent T tests analyzed the relationships of CRF with the markers. Findings: As CRF worsened, concentrations of EV-associated markers were upregulated. EV-associated fold changes of Eotaxin, hsp27, IP-10, MIP-3α, were significantly higher in fatigued participants compared to non-fatigued EBRT participants three months after treatment. This was not observed in soluble markers. Concentrations of EV-associated CRP and MCP-1, soluble survivin, IFNα2, IL-8, IL-12p70, and MCP-1 significantly correlated with lower (worsening) CRF scores at the start of and three months after treatment. Interpretation: Concentrations of EV-associated markers increased in fatigued men with prostate cancer three months after EBRT. Both EV-associated and soluble markers correlated with worsening CRF. EV-associated markers, which have not been previously studied in depth, may provide additional insights and serve as potential biomarkers for CRF. Keywords: Cancer-related fatigue; Cytokines; Exosomes; Extracellular vesicles.

参考サイト PubMed: exsome



バイオクイックニュース日本語版:エクソソーム特集

バイオクイックニュース日本語版
12月 17, 2019 バイオアソシエイツ

エクソソームが重度の前立腺癌促進伝達因子の送達をしていることが判明。 エクソソーム放出阻害が治療に有用であることが証明された。

ニューロン機能を支援する転写因子は、すでに再発した癌をさらに致命的にする可能性のある前立腺の細胞変換を可能にするようだ。 転写因子BRN4は主に中枢神経系と内耳で発現するが、稀であるが神経内分泌前立腺癌の患者でも増幅され過剰発現する最初の証拠がClinical Cancer Researchジャーナルで公開された。 この論文は「BRN4は去勢抵抗性前立腺癌における神経内分泌分化の新規ドライバーであり、BRN2を含む細胞外小胞で選択的に放出される(BRN4 Is a Novel Driver of…

ゲスト 771人 と メンバー 2人 がオンラインです